ANRS CO3 AQUITAINE - Natural history and sub-treatment of HIV infection
Head :
Dabis François, Équipe INSERM, U897, VIH & ADDICTIONS
Last update : 07/02/2015 | Version : 3 | ID : 3620
| General | |
| Identification | |
| Detailed name | Natural history and sub-treatment of HIV infection |
| Sign or acronym | ANRS CO3 AQUITAINE |
| CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | N° 88-84 (05/07/1988), N° 88-142 (29/11/1988) |
| General Aspects | |
| Medical area |
Immunology Infectious diseases |
| Keywords | HIV infection, epidemiological surveillance, patient care, immunology |
| Scientific investigator(s) (Contact) | |
| Name of the director | Dabis |
| Surname | François |
| Address | 146 rue Léo Saignat 33076 Bordeaux cedex |
| Phone | +33 (0)5 57 57 14 36 |
| francois.dabis@isped.u-bordeaux2.fr | |
| Unit | Équipe INSERM, U897, VIH & ADDICTIONS |
| Organization | ISPED- Institut de Santé Publique d'Epidémiologie et de |
| Collaborations | |
| Participation in projects, networks and consortia |
Yes |
| Details | Implication in a cohort network: EPAVIH, COPANA, AC7(COHORTES ANRS) Inclusion in a European project: CASCADE, DAD, ART-CC, EURO-SIDA, COHERE, HIV-TUBERCULOSIS |
| Others | Other related cohorts: fhdh; nice |
| Funding | |
| Funding status |
Mixed |
| Details | ANRS- Agence Nationale de la Recherche sur le Sida et les hépatites virales, SIDACTION |
| Governance of the database | |
| Sponsor(s) or organisation(s) responsible | CHU BORDEAUX |
| Organisation status |
Public |
| Sponsor(s) or organisation(s) responsible | UNIVERSITE DE BORDEAUX II |
| Organisation status |
Public |
| Additional contact | |
| Main features | |
| Type of database | |
| Type of database |
Study databases |
| Study databases (details) |
Longitudinal study (except cohorts) |
| Database recruitment is carried out by an intermediary |
A selection of health institutions and services |
| Database recruitment is carried out as part of an interventional study |
No |
| Additional information regarding sample selection. | Prospective |
| Database objective | |
| Main objective |
Main objective: study the natural history and sub-treatment of the infection by the HIV.
Secondary objectives: - Realize an epidemiological surveillance of the treatment of HIV infection - Analyze the progression of the infection and study the prognostic factors of this evolution - Evaluate the arrangements for patients caring - Study their impact on the disease progression |
| Inclusion criteria | HIV-positive patients, at any clinical stage .Seen at least once in consultation or hospitalization .13 years or older at the time of the inclusion in the study .Freely consent |
| Population type | |
| Age |
Adolescence (13 to 18 years) Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) Great age (80 years and more) |
| Population covered |
Sick population |
| Gender |
Male Woman |
| Geography area |
Departmental |
| French regions covered by the database |
Aquitaine Limousin Poitou-Charentes |
| Detail of the geography area | 13 hospital departments in Aquitaine: Bordeaux, Libourne, Bayonne, Dax, Pau, Périgueux, Villeneuve sur Lot, Mont de Marsan and Arcachon |
| Data collection | |
| Dates | |
| Date of first collection (YYYY or MM/YYYY) | 01/1987 |
| Size of the database | |
| Size of the database (number of individuals) |
[1000-10 000[ individuals |
| Details of the number of individuals | 8677 (31/12/2012) |
| Data | |
| Database activity |
Current data collection |
| Type of data collected |
Clinical data Biological data |
| Clinical data (detail) |
Medical registration |
| Details of collected clinical data | Clinical examination at inclusion and during the follow-up. Information collected through the clinical examination: - At inclusion, the record includes unique kind of variables: socio-demographic characteristics, risk factors for HIV infection, mode of transmission, date of first positive serology and diagnostic circumstances; eventually, date of the last negative serology, transfusion or risk exposure period. The inclusion record incorporates progressive variables: - Clinical examination data, specific pathologies diagnostics, classification according to the American centers for diseases control (CDC)(MMWR 1986;35:334-9) and the aids classification recognized by WHO/CDC, taken over by the General Health Direction (DGS) in 1987 (bull epidemiol HEBD 1987; (51):201-3) and modified in 1993 (bull epidemiol HEBD 1993 ; (11) : 47-8); - Sexual practices and drug addiction, lifestyle, cardiovascular risk factors; - Hematological, virological, immunological, biochemical and serological check; prescribed therapeutics, treatment history; During each follow-up, the questionnaire will allow to collect again all the information concerning progressive variables. |
| Biological data (detail) | Virological markers, immunological |
| Presence of a biobank |
Yes |
| Contents of biobank |
Serum Plasma DNA |
| Details of biobank content | Serum bank, Plasma bank, DNA bank |
| Health parameters studied |
Health event/morbidity Health event/mortality Health care consumption and services |
| Care consumption (detail) |
Hospitalization Medical/paramedical consultation |
| Procedures | |
| Data collection method | Clinical examination: manual data entry Biological examination: manual data entry |
| Quality procedure(s) used | Coherence request after computer data entry. Missing data checked back to the original file. Doctors remainders for follow-up visits. Internal and external quality audit reports every 2 years. Validation of deaths. Patients receive information about the use of their data. |
| Participant monitoring |
Yes |
| Details on monitoring of participants | Unlimited duration. |
| Links to administrative sources |
Yes |
| Linked administrative sources (detail) | CépiDC (Epidemiological center for medical causes of death |
| Promotion and access | |
| Promotion | |
| Link to the document | http://www.hal.inserm.fr/ANRSCO3 |
| Description | List of publications in HAL |
| Link to the document | http://www.ncbi.nlm.nih.gov/pubmed/?term=%28ANRS+CO3+Aquitaine+Cohort%29+OR+ANRS-CO3+OR+%28D.A.D+OR+DAD%29+AND+%28Dabis[author]+OR+Worm[author]+OR+sabin[author]+OR+reiss[author]+OR+Friis-Moller[author]+OR+law[author]%29%29+OR+%28cohere+AND+%28hiv+OR+AIDS%29%29+OR+ART-CC+OR+%22cascade+collaboration%22+OR+HIV-causal+collaboration+NOT+23686153[uid] |
| Description | List of publications in Pubmed |
| Access | |
| Terms of data access (charter for data provision, format of data, availability delay) | Data utilization possible for academic teams and for industrials. Access condition in agreement with the steering committee |
| Access to aggregated data |
Access on specific project only |
| Access to individual data |
Access on specific project only |
